Loading
Latest filing published 27 Feb 2017 for Acasti Pharma Inc., €55k.
No signal scores available.
All filings by Janelle D'Alvise on record concern Acasti Pharma Inc. In total, 2 filings cover trades dated from 12 May 2016 to 21 February 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 27 February 2017: a transaction of €55k, in Acasti Pharma Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations